Archimedes Gets a Dose of Green

Reuters reports that European pharmaceutical giant, Archimedes has raised had raised 65 million pounds ($97,892,414.29 USD) in the largest funding round by a private European biopharma company in the last 15 years. The money will be used to establish Archimedes' operations in the United State, expand its business in Europe and support the global launch of its novel nasal spray for cancer pain PecFent.

Learn more:

• Drug Firm Archimedes Raises £65 Mln
• Archimedes gets $100M bankroll and names a new CEO

Share this article with your social network, just click below to share now!

Share |